Alterations of the Characteristics of the Circadian Rest-Activity Rhythm of Cancer In-Patients
The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. Th...
Saved in:
Published in | Chronobiology international Vol. 24; no. 6; pp. 1179 - 1197 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa UK Ltd
01.01.2007
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0742-0528 1525-6073 |
DOI | 10.1080/07420520701800868 |
Cover
Abstract | The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. The rest-activity rhythm was studied non-invasively by wrist actigraphy, and compared with 35 age-matched apparently healthy subjects (22 males and 13 females). All subjects wore an Actiwatch (AW64, Mini Mitter Co. Inc., USA) for at least 4-7 consecutive days. Fifteen-second epoch length was selected for gathering actigraphy data. In addition, several sleep parameters, such as time in bed, assumed sleep, actual sleep time, actual wake time, sleep efficiency, sleep latency, sleep bouts, wake bouts, and fragmentation index, were also recorded. Data were analyzed using several statistical techniques, such as cosinor rhythmometry, spectral analysis, ANOVA, Duncan's multiple-range test, and t-test. Dichotomy index (I<O) and autocorrelation coefficient (r24) were also computed. The results validated a statistically significant circadian rhythm in rest-activity with a prominent period of 24 h for most cancer patients and control subjects. Results of this study further revealed that cancer patients do experience a drastic alteration in the circadian rest-activity rhythm parameters. Both the dichotomy index and r24 declined in the group of cancer patients. The occurrence of the peak (acrophase, Ø) of the rest-activity rhythm was earlier (p<0.001) in cancer patients than age- and gender-matched control subjects. Results of sleep parameters revealed that cancer patients spent longer time in bed, had longer assumed and actual sleep durations, and a greater number of sleep and wake bouts compared to control subjects. Further, nap frequency, total nap duration, average nap, and total nap duration per 1 h awake span were statistically significantly higher in cancer patients than control subjects. In conclusion, the results of the present study document the disruption of the circadian rhythm in rest-activity of cancer in-patients, with a dampening of amplitude, lowering of mean level of activity, and phase advancement. These alterations of the circadian rhythm characteristics could be attributed to disease, irrespective of variability due to gender, sites of cancer, and timings of therapies. These results might help in designing patient-specific chronotherapeutic protocols. |
---|---|
AbstractList | The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. The rest-activity rhythm was studied non-invasively by wrist actigraphy, and compared with 35 age-matched apparently healthy subjects (22 males and 13 females). All subjects wore an Actiwatch (AW64, Mini Mitter Co. Inc., USA) for at least 4-7 consecutive days. Fifteen-second epoch length was selected for gathering actigraphy data. In addition, several sleep parameters, such as time in bed, assumed sleep, actual sleep time, actual wake time, sleep efficiency, sleep latency, sleep bouts, wake bouts, and fragmentation index, were also recorded. Data were analyzed using several statistical techniques, such as cosinor rhythmometry, spectral analysis, ANOVA, Duncan's multiple-range test, and t-test. Dichotomy index (I<O) and autocorrelation coefficient (r24) were also computed. The results validated a statistically significant circadian rhythm in rest-activity with a prominent period of 24 h for most cancer patients and control subjects. Results of this study further revealed that cancer patients do experience a drastic alteration in the circadian rest-activity rhythm parameters. Both the dichotomy index and r24 declined in the group of cancer patients. The occurrence of the peak (acrophase, Ø) of the rest-activity rhythm was earlier (p<0.001) in cancer patients than age- and gender-matched control subjects. Results of sleep parameters revealed that cancer patients spent longer time in bed, had longer assumed and actual sleep durations, and a greater number of sleep and wake bouts compared to control subjects. Further, nap frequency, total nap duration, average nap, and total nap duration per 1 h awake span were statistically significantly higher in cancer patients than control subjects. In conclusion, the results of the present study document the disruption of the circadian rhythm in rest-activity of cancer in-patients, with a dampening of amplitude, lowering of mean level of activity, and phase advancement. These alterations of the circadian rhythm characteristics could be attributed to disease, irrespective of variability due to gender, sites of cancer, and timings of therapies. These results might help in designing patient-specific chronotherapeutic protocols. The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. The rest-activity rhythm was studied non-invasively by wrist actigraphy, and compared with 35 age-matched apparently healthy subjects (22 males and 13 females). All subjects wore an Actiwatch (AW64, Mini Mitter Co. Inc., USA) for at least 4-7 consecutive days. Fifteen-second epoch length was selected for gathering actigraphy data. In addition, several sleep parameters, such as time in bed, assumed sleep, actual sleep time, actual wake time, sleep efficiency, sleep latency, sleep bouts, wake bouts, and fragmentation index, were also recorded. Data were analyzed using several statistical techniques, such as cosinor rhythmometry, spectral analysis, ANOVA, Duncan's multiple-range test, and t-test. Dichotomy index (I<O) and autocorrelation coefficient (r24) were also computed. The results validated a statistically significant circadian rhythm in rest-activity with a prominent period of 24 h for most cancer patients and control subjects. Results of this study further revealed that cancer patients do experience a drastic alteration in the circadian rest-activity rhythm parameters. Both the dichotomy index and r24 declined in the group of cancer patients. The occurrence of the peak (acrophase, Ø) of the rest-activity rhythm was earlier (p<0.001) in cancer patients than age- and gender-matched control subjects. Results of sleep parameters revealed that cancer patients spent longer time in bed, had longer assumed and actual sleep durations, and a greater number of sleep and wake bouts compared to control subjects. Further, nap frequency, total nap duration, average nap, and total nap duration per 1 h awake span were statistically significantly higher in cancer patients than control subjects. In conclusion, the results of the present study document the disruption of the circadian rhythm in rest-activity of cancer in-patients, with a dampening of amplitude, lowering of mean level of activity, and phase advancement. These alterations of the circadian rhythm characteristics could be attributed to disease, irrespective of variability due to gender, sites of cancer, and timings of therapies. These results might help in designing patient-specific chronotherapeutic protocols.The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting of 19 males and 12 females, were randomly selected from the Regional Cancer Center, Pandit Jawaharlal Nehru Medical College, Raipur, India. The rest-activity rhythm was studied non-invasively by wrist actigraphy, and compared with 35 age-matched apparently healthy subjects (22 males and 13 females). All subjects wore an Actiwatch (AW64, Mini Mitter Co. Inc., USA) for at least 4-7 consecutive days. Fifteen-second epoch length was selected for gathering actigraphy data. In addition, several sleep parameters, such as time in bed, assumed sleep, actual sleep time, actual wake time, sleep efficiency, sleep latency, sleep bouts, wake bouts, and fragmentation index, were also recorded. Data were analyzed using several statistical techniques, such as cosinor rhythmometry, spectral analysis, ANOVA, Duncan's multiple-range test, and t-test. Dichotomy index (I<O) and autocorrelation coefficient (r24) were also computed. The results validated a statistically significant circadian rhythm in rest-activity with a prominent period of 24 h for most cancer patients and control subjects. Results of this study further revealed that cancer patients do experience a drastic alteration in the circadian rest-activity rhythm parameters. Both the dichotomy index and r24 declined in the group of cancer patients. The occurrence of the peak (acrophase, Ø) of the rest-activity rhythm was earlier (p<0.001) in cancer patients than age- and gender-matched control subjects. Results of sleep parameters revealed that cancer patients spent longer time in bed, had longer assumed and actual sleep durations, and a greater number of sleep and wake bouts compared to control subjects. Further, nap frequency, total nap duration, average nap, and total nap duration per 1 h awake span were statistically significantly higher in cancer patients than control subjects. In conclusion, the results of the present study document the disruption of the circadian rhythm in rest-activity of cancer in-patients, with a dampening of amplitude, lowering of mean level of activity, and phase advancement. These alterations of the circadian rhythm characteristics could be attributed to disease, irrespective of variability due to gender, sites of cancer, and timings of therapies. These results might help in designing patient-specific chronotherapeutic protocols. |
Author | Roy, Sushmita Parganiha, Arti Soni, Rakesh Pati, Atanu Kumar Kar, Anjana Choudhary, Vivek |
Author_xml | – sequence: 1 givenname: Atanu Kumar surname: Pati fullname: Pati, Atanu Kumar email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India – sequence: 2 givenname: Arti surname: Parganiha fullname: Parganiha, Arti email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India – sequence: 3 givenname: Anjana surname: Kar fullname: Kar, Anjana email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India – sequence: 4 givenname: Rakesh surname: Soni fullname: Soni, Rakesh email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India – sequence: 5 givenname: Sushmita surname: Roy fullname: Roy, Sushmita email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India – sequence: 6 givenname: Vivek surname: Choudhary fullname: Choudhary, Vivek email: akpati19@gmail.com or akpati19@hotmail.com organization: 1School of Life Sciences, Pt. Ravishankar Shukla University, Raipur, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18075806$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kF2L1DAUQIOsuLOrP8AX6ZNv1Zs2TTPoyzD4sbCgLPpquE1vaJY2WZOMMv_ejLOyqDBPCck5N-FcsDMfPDH2nMMrDgpeQy8a6BrogSsAJdUjtuJd09US-vaMrQ73dQHUObtI6RYKA7J9ws4L3ndlv2LfNnOmiNkFn6pgqzxRtZ0woinHLmVnHo5dNDg69NUNpVxvTHY_XN5XN9M-T8uB2qI3FKsrX38uE8nn9JQ9tjgnena_XrKv79992X6srz99uNpurmsjQORajdQ0A-fUAAlhuAUEPnCLuB5IcAmKtyTWQpoBRqGoa6SRdpS97RtoFbaX7OVx7l0M33fle3pxydA8o6ewS1quQfaw5gV8cQ_uhoVGfRfdgnGv_xQpAD8CJoaUItkHBPShuv6venH6fxzj8u-mOaKbT5pvj6bzNsQFf4Y4jzrjfg7RxpLTJd2e0t_8pU-Ec54MRtK3YRd9SX7i8V_AhqmH |
CitedBy_id | crossref_primary_10_1080_07420520902820939 crossref_primary_10_1097_NCC_0000000000001188 crossref_primary_10_3390_cancers15153784 crossref_primary_10_1097_NCC_0000000000000299 crossref_primary_10_1371_journal_pone_0258135 crossref_primary_10_1007_s00520_015_2883_6 crossref_primary_10_1097_PPO_0000000000000070 crossref_primary_10_1080_07420528_2020_1756839 crossref_primary_10_1080_07420520802678452 crossref_primary_10_1080_09291016_2019_1628406 crossref_primary_10_1016_j_patbio_2011_01_001 crossref_primary_10_3109_15412555_2013_836167 crossref_primary_10_1002_jts_22359 crossref_primary_10_1097_NCC_0000000000000953 crossref_primary_10_1080_09291016_2015_1004840 crossref_primary_10_1093_sleep_32_9_1155 crossref_primary_10_3109_07420520903245276 crossref_primary_10_1097_NCC_0000000000000163 crossref_primary_10_1097_NCC_0b013e3182194a25 crossref_primary_10_1002_pon_4862 crossref_primary_10_1155_2013_564340 crossref_primary_10_3389_fonc_2023_1240284 crossref_primary_10_3109_07420528_2015_1053909 crossref_primary_10_1016_j_ejim_2024_12_031 crossref_primary_10_5664_jcsm_8458 crossref_primary_10_1093_sleep_zsab246 crossref_primary_10_1080_09291016_2021_1945788 crossref_primary_10_3389_fonc_2022_1009064 crossref_primary_10_1145_3314395 crossref_primary_10_1080_09291016_2016_1251912 crossref_primary_10_1080_09291016_2018_1559415 crossref_primary_10_1007_s41105_023_00488_8 crossref_primary_10_1249_MSS_0b013e3182399e5b crossref_primary_10_1016_j_jpainsymman_2019_01_015 crossref_primary_10_1080_09291016_2012_667979 crossref_primary_10_1177_1534735409352028 crossref_primary_10_1080_15402002_2011_634940 crossref_primary_10_1080_07420528_2017_1337032 crossref_primary_10_1016_j_cct_2022_106877 crossref_primary_10_1097_NCC_0b013e3181f65d9b crossref_primary_10_2147_NSS_S251743 crossref_primary_10_3390_clockssleep3040042 crossref_primary_10_1038_bjc_2016_356 crossref_primary_10_1186_s13063_020_4196_4 crossref_primary_10_2196_jmir_6303 crossref_primary_10_2139_ssrn_4111228 crossref_primary_10_1002_pon_3553 crossref_primary_10_1080_07420528_2017_1286501 crossref_primary_10_1002_pbc_25147 crossref_primary_10_1016_j_ddmod_2011_05_001 crossref_primary_10_1111_ecc_13233 |
Cites_doi | 10.1007/s00520-005-0861-0 10.1158/1078-0432.CCR-04-2000 10.1081/CBI-120002593 10.1016/S0885-3924(99)00008-1 10.1081/CBI-120002600 10.1016/j.jpainsymman.2006.03.014 10.1016/S1470-2045(00)00326-0 10.1080/07420520601055308 10.1002/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L 10.1007/s00520-001-0317-0 10.1188/05.ONF.E98-E126 10.1016/B978-0-08-034135-4.50006-X 10.1080/07420520600827152 10.1016/j.biopha.2003.08.012 10.1007/s10552-005-9004-7 10.3109/07420529609040839 10.1038/sj.bjc.6602859 10.1097/00000421-198212000-00014 10.1081/CBI-120002606 10.1007/s00432-001-0309-y 10.1093/sleep/26.3.337 10.1111/j.1749-6632.1994.tb56855.x 10.1093/jnci/94.9.690 10.1080/07420520500263235 10.1146/annurev.pharmtox.47.120505.105208 10.1007/BF01198101 10.1080/07420520500545813 10.1080/09291010600772626 |
ContentType | Journal Article |
Copyright | 2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007 |
Copyright_xml | – notice: 2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/07420520701800868 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1525-6073 |
EndPage | 1197 |
ExternalDocumentID | 18075806 10_1080_07420520701800868 280135 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 00X 03L 0BK 0R~ 0VX 29B 30N 36B 4.4 53G 5GY 5RE 5VS AAAVI AAAVZ AAGME AAJMT AALDU AALIY AAMIU AAOAP AAPUL AAPXX AAQRR ABCCY ABFIM ABFMO ABIVO ABJNI ABJVF ABLIJ ABLKL ABQHQ ABXUL ABXYU ACBBU ACDHJ ACFUF ACGEJ ACGFS ACKOT ACQMU ACTIO ACZPZ ADCVX ADFCX ADGTB ADGTR ADOPC ADRBQ ADXPE AEGYZ AEISY AENEX AEOZL AEPSL AEYOC AEYQI AFDYB AFKVX AFWLO AGDLA AHDLD AIJEM AIRXU AJWEG AKBVH AKOOK ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU APNXG AQRUH AURDB AWQZV AWYRJ BABNJ BFWEY BLEHA CAG CCCUG COF CS3 CWRZV DGEBU DKSSO DU5 EBS EJD EMOBN F5P FA8 HGUVV HZ~ IPNFZ JEPSP KRBQP KWAYT KYCEM LJTGL M44 M4Z O9- OWHGL P2P PCLFJ RIG RNANH ROSJB RTWRZ TFDNU TFL TFT TFW TQWBC TTHFI UAP V1S XJT YHZ ZGOLN ZXP ~02 ~1N ABPAQ AHDZW AIZAD H13 TBQAZ TDBHL TUROJ AAGDL AAHIA AAYXX ABTAA ADYSH AFRVT AIYEW AMPGV CITATION NUSFT CGR CUY CVF ECM EIF NPM 7X8 ACFTK TASJS |
ID | FETCH-LOGICAL-c404t-8de22b11e20e44c1f0a01b1faa9be4160813e4946cb0d48e526c6fd67f72038a3 |
ISSN | 0742-0528 |
IngestDate | Thu Sep 04 19:13:52 EDT 2025 Thu Apr 03 07:05:54 EDT 2025 Tue Jul 01 01:20:42 EDT 2025 Thu Apr 24 23:04:57 EDT 2025 Wed Dec 25 09:03:51 EST 2024 Thu Feb 29 06:23:56 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c404t-8de22b11e20e44c1f0a01b1faa9be4160813e4946cb0d48e526c6fd67f72038a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18075806 |
PQID | 69067091 |
PQPubID | 23479 |
PageCount | 19 |
ParticipantIDs | proquest_miscellaneous_69067091 crossref_citationtrail_10_1080_07420520701800868 informaworld_taylorfrancis_310_1080_07420520701800868 crossref_primary_10_1080_07420520701800868 informahealthcare_journals_10_1080_07420520701800868 pubmed_primary_18075806 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-01-01 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – month: 01 year: 2007 text: 2007-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Chronobiology international |
PublicationTitleAlternate | Chronobiol Int |
PublicationYear | 2007 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
References | Mormont M C (CIT0023) 2003; 9 Mormont M C (CIT0025) 1996; 44 CIT0030 Rich T (CIT0032) 2005; 11 Chevalier V (CIT0007) 2003; 10 CIT0012 Oken M M (CIT0029) 1982; 5 Kobayashi M (CIT0013) 2002; 19 Ancoli‐Israel S (CIT0002) 2006; 14 Filipski E (CIT0011) 2002; 94 De Prins J (CIT0008) 1986; 2 Berger A M (CIT0005) 2005; 32 Touitou Y (CIT0034) 1995; 121 CIT0035 CIT0015 Lévi F (CIT0016) 2007; 47 Fernandes R (CIT0010) 2006; 32 Littner M (CIT0018) 2003; 26 Nelson W (CIT0028) 1979; 6 Raida M (CIT0031) 2002; 128 Berger A M (CIT0004) 1998; 25 Mormont M C (CIT0026) 2000; 6 Levin R D (CIT0017) 2005; 93 Lévi F (CIT0014) 2001; 2 CIT0020 CIT0001 Eriguchi M (CIT0009) 2003; 57 Miaskowski C (CIT0019) 1999; 17 Monk T H (CIT0021) 2006; 23 Mormont M C (CIT0022) 1997; 70 CIT0024 CIT0027 Roscoe J A (CIT0033) 2002; 10 CIT0006 Bartsch C (CIT0003) 1994; 719 |
References_xml | – volume: 14 start-page: 201 year: 2006 ident: CIT0002 publication-title: Support Care Cancer doi: 10.1007/s00520-005-0861-0 – volume: 11 start-page: 1757 year: 2005 ident: CIT0032 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-04-2000 – volume: 10 start-page: 733 year: 2003 ident: CIT0007 publication-title: Oncol. Reports – ident: CIT0027 doi: 10.1081/CBI-120002593 – volume: 17 start-page: 320 year: 1999 ident: CIT0019 publication-title: J. Pain Symptom Manage. doi: 10.1016/S0885-3924(99)00008-1 – volume: 19 start-page: 237 year: 2002 ident: CIT0013 publication-title: Chronobiol. Int. doi: 10.1081/CBI-120002600 – volume: 32 start-page: 245 year: 2006 ident: CIT0010 publication-title: J. Pain Symptom Manage. doi: 10.1016/j.jpainsymman.2006.03.014 – volume: 2 start-page: 307 year: 2001 ident: CIT0014 publication-title: The Lancet Oncol. doi: 10.1016/S1470-2045(00)00326-0 – ident: CIT0035 doi: 10.1080/07420520601055308 – volume: 44 start-page: 165 year: 1996 ident: CIT0025 publication-title: Pathol. Biol. (Paris) – volume: 70 start-page: 241 year: 1997 ident: CIT0022 publication-title: Int. J. Cancer doi: 10.1002/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L – volume: 10 start-page: 329 year: 2002 ident: CIT0033 publication-title: Support Care Cancer. doi: 10.1007/s00520-001-0317-0 – volume: 32 start-page: 98 year: 2005 ident: CIT0005 publication-title: Oncol. Nurs. Forum. doi: 10.1188/05.ONF.E98-E126 – volume: 2 start-page: 27 year: 1986 ident: CIT0008 publication-title: Annu. Rev. Chronopharmacol. doi: 10.1016/B978-0-08-034135-4.50006-X – volume: 23 start-page: 831 year: 2006 ident: CIT0021 publication-title: Chronobiol. Int. doi: 10.1080/07420520600827152 – volume: 57 start-page: 92 year: 2003 ident: CIT0009 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2003.08.012 – ident: CIT0015 doi: 10.1007/s10552-005-9004-7 – ident: CIT0020 doi: 10.3109/07420529609040839 – volume: 93 start-page: 1202 year: 2005 ident: CIT0017 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6602859 – volume: 9 start-page: 155 year: 2003 ident: CIT0023 publication-title: American Cancer Society – volume: 25 start-page: 51 year: 1998 ident: CIT0004 publication-title: Oncol. Nurs. Forum – volume: 5 start-page: 649 year: 1982 ident: CIT0029 publication-title: Am. J. Clin. Oncol. doi: 10.1097/00000421-198212000-00014 – ident: CIT0024 doi: 10.1081/CBI-120002606 – volume: 128 start-page: 96 year: 2002 ident: CIT0031 publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-001-0309-y – volume: 26 start-page: 337 year: 2003 ident: CIT0018 publication-title: Sleep doi: 10.1093/sleep/26.3.337 – volume: 6 start-page: 305 year: 1979 ident: CIT0028 publication-title: Chronobiologia – volume: 719 start-page: 502 year: 1994 ident: CIT0003 publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.1994.tb56855.x – ident: CIT0001 – volume: 94 start-page: 690 year: 2002 ident: CIT0011 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/94.9.690 – ident: CIT0012 doi: 10.1080/07420520500263235 – volume: 47 start-page: 593 year: 2007 ident: CIT0016 publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev.pharmtox.47.120505.105208 – volume: 121 start-page: 181 year: 1995 ident: CIT0034 publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/BF01198101 – ident: CIT0006 doi: 10.1080/07420520500545813 – ident: CIT0030 doi: 10.1080/09291010600772626 – volume: 6 start-page: 3038 year: 2000 ident: CIT0026 publication-title: Clin. Cancer Res. |
SSID | ssj0008063 |
Score | 2.0229442 |
Snippet | The aim of the present study was to evaluate the characteristics of the circadian rest-activity rhythm of cancer patients. Thirty-one in-patients, consisting... |
SourceID | proquest pubmed crossref informaworld informahealthcare |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1179 |
SubjectTerms | Activity Cycles - physiology Adolescent Adult Aged Chronobiology Phenomena Circadian rhythm Circadian Rhythm - physiology Dichotomy index Female Head and neck cancer Humans Male Middle Aged Neoplasms - physiopathology Reproductive organ cancer Rest - physiology Rest-activity pattern Sleep - physiology |
Title | Alterations of the Characteristics of the Circadian Rest-Activity Rhythm of Cancer In-Patients |
URI | https://www.tandfonline.com/doi/abs/10.1080/07420520701800868 https://www.ncbi.nlm.nih.gov/pubmed/18075806 https://www.proquest.com/docview/69067091 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJxAvaAwY5ZoHnpiCHNfO5TEaoII0hMomJl4i23XUwUhRmz6MJ34Cf4I_xi_hOL4kC1vFeIkqx3Hqnq_nYh9_B6FnkRBg9gC8NMI4pJxkocBchilYF6zAf8hKvaB_8C6eHNG3x-x4MPjVyVpa1-KF_H7huZL_kSq0gVz1KdkrSNYPCg3wGeQLV5AwXP9Jxvlpw4nsctm0D7nfI2B2zSdLaVgIpmAGfIZDLm3xiOn8rJ5_NYe1AAZL0Bu-03tDvbrq-rENp65ncDrpLiu2m1ImUyAH93O916Ryt7eaE6BmrymHeXm1b9K98-ozr7y9-LBoyk7tTfkXtZqfW6ZIOssURptBDB5iZk-CK6ttCQtjbGqZOHVsjlRb2HV1qyav69hpvf95oQ2wSZPwPp3jk2iGMojb0tbguU3-nh302YmRo03tD3ENbZEEXLQh2sonLz999CY_tSX73Bzd9rkmce8Pcs4B2rb0uHOf7NejzL088GkcoMNtdMtGLkFuYHgbDVS1g66bWqZnO-jGgc3SuINEB5fBogwAgEEPl77Z4TLQuPz946dDZGAQqfsZRAZvKrjtsHgXHb1-dbg_CW0tj1BSTOswnSlCRBQpghWlMioxx5GISs4zoSAoAM90rGhGYynwjKaKkVjG5SxOSp0nkPLxPTSsFpW6j4KEZVTSGaNSZRBuQEQMwzA9bEoEJ2yEsPuBC2mJ7nW9ldPiUsGO0HP_yDfD8rKpM_1LaoXVCqtNj7GuYIu6WZErTfmcYrzhuacOAQWofr2fxyu1WK8KzTGegL8_QrsGGO131xTjAMoHV5nXQ3Sz_eM-QsN6uVaPweOuxROL9z_gNsph |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED5tnRi8bIyfHRvkYU9IBid10uSxqkBl0GpCIPE0K3YdFVFS1KYP5a_nLnbKKKwPvEZnJ06-iz_fnb4D-OUrhdseglf4nDORBglTPNUsxt2FG-QPSUYB_W4v6lyL3zfhjQu4TVxZJZ2hMysUUf6rybkpGF2VxB3TeY7qN5qkPoWcPP4In0Kk4lTS1-C9-Z84dp3U0JyhfVxlNd-a4sW-tO5USwfzGqwFJdP_89FyXzr9CrJakS1HuTuaFupIPy6IPb5_yevwxVFWr2Ux9g0-mHwDVmwTy9kGfO669Pwm_G0NS5FmgrI3yjwkl177pSL0_PLtWJeyCN4lro61tO1i4V0OZsXgnqzahMexd5azP1b7dbIF16cnV-0Ocw0cmBZcFCzumyBQvm8CboTQfsZT7is_S9NEGWSCSEcaRiQi0or3RWzCINJR1o-aGSWH47SxDbV8lJtd8JphIrToh0KbBDkmHoNwmpCmjQOVBmEdePX5pHbq5tRkYyj9SgR18Q3W4XA-5MFKeywzFq8wIZ27T5YNC_-FjSzKMExme6bIxpJxBxW-JPo7JXHS3IymE0nC0k0keXXYsbB7fnbSlUbIf3_nPQ9gtXPVvZAXZ73zPVizQWyKNf2AWjGemp_Ivgq1X7rYE3qlHbQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB1RqiIuQGkL2_KRQ0-VTJ3EySbH1cIKaFkhVCROjWLH1lZAFm2yB_j1zMTOFrZlD1yjsfP1xn6eGb0B-OpLidseglf4nDORBymTPFcswd2Fa-QPqaGA_tkwPr4Up1fRlavNqVxZJZ2hjRWKaNZqcu67wrQVcd_pOEflG10Sn0JKnryBtzEPU5LOD_lwthAnrpEamjO0T9qk5v-meLYtbTjR0tGsBGtOyPRlOtpsS4N123u1atQMqRrl-mBaywP1MKf1-Oo33oA1R1i9nkXYe1jS5Sa8sy0s7zdh5cwl5z_A795NI9FMQPbGxkNq6fWf60HPLv-ZqEYUwbvAl2M9ZXtYeBej-3p0S1Z9QuPEOynZuVV-rT7C5eDoV_-YufYNTAkuapYUOgik7-uAayGUb3jOfembPE-lRh6IZCTUIhWxkrwQiY6CWMWmiLuGUsNJHn6C5XJc6m3wulEqlCgioXSKDBMPQThNRNMmgcyDqAO8_XuZctrm1GLjJvNbCdT5L9iBb7Mhd1bYY5Gx-AcSmXP2atGw6ClqsroJwhjbMSULF4zbb-GVobdTCicv9XhaZSQr3UWK14Eti7q_z06q0oj4z6-85z6snB8Osp8nwx9fYNVGsCnQtAPL9WSqd5F61XKvcbBH7C0cYQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alterations+of+the+Characteristics+of+the+Circadian+Rest%E2%80%90Activity+Rhythm+of+Cancer+In%E2%80%90Patients&rft.jtitle=Chronobiology+international&rft.au=Pati%2C+Atanu+Kumar&rft.au=Parganiha%2C+Arti&rft.au=Kar%2C+Anjana&rft.au=Soni%2C+Rakesh&rft.date=2007-01-01&rft.issn=0742-0528&rft.eissn=1525-6073&rft.volume=24&rft.issue=6&rft.spage=1179&rft.epage=1197&rft_id=info:doi/10.1080%2F07420520701800868&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_07420520701800868 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-0528&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-0528&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-0528&client=summon |